Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering
Authorized Users Only
2011
Authors
Stanić, VojislavJanacković, Djordje
Dimitrijević, Suzana

Tanasković, Slađana B.
Mitrić, Miodrag

Pavlović, Mirjana S.
Krstić, Aleksandra

Jovanović, Dragoljub
Raicević, Slavica
Article (Published version)

Metadata
Show full item recordAbstract
Monophase silver-doped hydroxyapatite (AgxCa10-x(PO4)(6)(OH)(2); 0.002 lt = x lt = 0.04) nanoparticles were prepared using a neutralization method and investigated with respect to potential medical applications. This method consists of dissolving Ag2O in solution of H3PO4, and the slow addition to suspension of Ca(OH)(2) was applied for the purpose of homogenous distribution of silver ions. Characterization studies from XRD, TEM and FTIR spectra showed that obtained crystals are monophase hydroxyapatites and that particles of all samples are of nano size, with average length of 70nm and about 15-25nm in diameter. Antimicrobial studies have demonstrated that all silver-doped hydroxyapatite samples exhibit excellent antimicrobial activity in vitro against the following pathogens: Staphylococcus aureus, Escherichia coli and Candida albicans. The hydroxyapatite sample with the highest content of silver has shown the highest antimicrobial activity; killed all cells of E. coli and brought ...to more than 99% reduction in viable counts of S. aureus and C. albicans. The atomic force microscopic studies illustrate that silver-doped hydroxyapatite sample causes considerable morphological changes of microorganism cells which might be the cause of cells' death. Hemolysis ratios of the silver-doped hydroxyapatite samples were below 3%, indicating good blood compatibility and that are promising as biomaterials. Crown Copyright (C) 2010 Published by Elsevier B. V. All rights reserved.
Keywords:
Hydroxyapatite / Silver / Antimicrobial / Bone / Hemolysis / AFMSource:
Applied Surface Science, 2011, 257, 9, 4510-4518Publisher:
- Elsevier, Amsterdam
Funding / projects:
- Ministry of Science and Environmental Protection of the Republic of Serbia
DOI: 10.1016/j.apsusc.2010.12.113
ISSN: 0169-4332
WoS: 000286459600114
Scopus: 2-s2.0-78951487082
Collections
Institution/Community
Institut za medicinska istraživanjaTY - JOUR AU - Stanić, Vojislav AU - Janacković, Djordje AU - Dimitrijević, Suzana AU - Tanasković, Slađana B. AU - Mitrić, Miodrag AU - Pavlović, Mirjana S. AU - Krstić, Aleksandra AU - Jovanović, Dragoljub AU - Raicević, Slavica PY - 2011 UR - http://rimi.imi.bg.ac.rs/handle/123456789/383 AB - Monophase silver-doped hydroxyapatite (AgxCa10-x(PO4)(6)(OH)(2); 0.002 lt = x lt = 0.04) nanoparticles were prepared using a neutralization method and investigated with respect to potential medical applications. This method consists of dissolving Ag2O in solution of H3PO4, and the slow addition to suspension of Ca(OH)(2) was applied for the purpose of homogenous distribution of silver ions. Characterization studies from XRD, TEM and FTIR spectra showed that obtained crystals are monophase hydroxyapatites and that particles of all samples are of nano size, with average length of 70nm and about 15-25nm in diameter. Antimicrobial studies have demonstrated that all silver-doped hydroxyapatite samples exhibit excellent antimicrobial activity in vitro against the following pathogens: Staphylococcus aureus, Escherichia coli and Candida albicans. The hydroxyapatite sample with the highest content of silver has shown the highest antimicrobial activity; killed all cells of E. coli and brought to more than 99% reduction in viable counts of S. aureus and C. albicans. The atomic force microscopic studies illustrate that silver-doped hydroxyapatite sample causes considerable morphological changes of microorganism cells which might be the cause of cells' death. Hemolysis ratios of the silver-doped hydroxyapatite samples were below 3%, indicating good blood compatibility and that are promising as biomaterials. Crown Copyright (C) 2010 Published by Elsevier B. V. All rights reserved. PB - Elsevier, Amsterdam T2 - Applied Surface Science T1 - Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering EP - 4518 IS - 9 SP - 4510 VL - 257 DO - 10.1016/j.apsusc.2010.12.113 UR - conv_2452 ER -
@article{ author = "Stanić, Vojislav and Janacković, Djordje and Dimitrijević, Suzana and Tanasković, Slađana B. and Mitrić, Miodrag and Pavlović, Mirjana S. and Krstić, Aleksandra and Jovanović, Dragoljub and Raicević, Slavica", year = "2011", abstract = "Monophase silver-doped hydroxyapatite (AgxCa10-x(PO4)(6)(OH)(2); 0.002 lt = x lt = 0.04) nanoparticles were prepared using a neutralization method and investigated with respect to potential medical applications. This method consists of dissolving Ag2O in solution of H3PO4, and the slow addition to suspension of Ca(OH)(2) was applied for the purpose of homogenous distribution of silver ions. Characterization studies from XRD, TEM and FTIR spectra showed that obtained crystals are monophase hydroxyapatites and that particles of all samples are of nano size, with average length of 70nm and about 15-25nm in diameter. Antimicrobial studies have demonstrated that all silver-doped hydroxyapatite samples exhibit excellent antimicrobial activity in vitro against the following pathogens: Staphylococcus aureus, Escherichia coli and Candida albicans. The hydroxyapatite sample with the highest content of silver has shown the highest antimicrobial activity; killed all cells of E. coli and brought to more than 99% reduction in viable counts of S. aureus and C. albicans. The atomic force microscopic studies illustrate that silver-doped hydroxyapatite sample causes considerable morphological changes of microorganism cells which might be the cause of cells' death. Hemolysis ratios of the silver-doped hydroxyapatite samples were below 3%, indicating good blood compatibility and that are promising as biomaterials. Crown Copyright (C) 2010 Published by Elsevier B. V. All rights reserved.", publisher = "Elsevier, Amsterdam", journal = "Applied Surface Science", title = "Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering", pages = "4518-4510", number = "9", volume = "257", doi = "10.1016/j.apsusc.2010.12.113", url = "conv_2452" }
Stanić, V., Janacković, D., Dimitrijević, S., Tanasković, S. B., Mitrić, M., Pavlović, M. S., Krstić, A., Jovanović, D.,& Raicević, S.. (2011). Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering. in Applied Surface Science Elsevier, Amsterdam., 257(9), 4510-4518. https://doi.org/10.1016/j.apsusc.2010.12.113 conv_2452
Stanić V, Janacković D, Dimitrijević S, Tanasković SB, Mitrić M, Pavlović MS, Krstić A, Jovanović D, Raicević S. Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering. in Applied Surface Science. 2011;257(9):4510-4518. doi:10.1016/j.apsusc.2010.12.113 conv_2452 .
Stanić, Vojislav, Janacković, Djordje, Dimitrijević, Suzana, Tanasković, Slađana B., Mitrić, Miodrag, Pavlović, Mirjana S., Krstić, Aleksandra, Jovanović, Dragoljub, Raicević, Slavica, "Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering" in Applied Surface Science, 257, no. 9 (2011):4510-4518, https://doi.org/10.1016/j.apsusc.2010.12.113 ., conv_2452 .